Individualized therapy for metastatic colorectal cancer.
about
Recent applications of chemosensitivity tests for colorectal cancer treatmentPharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsSur8 mediates tumorigenesis and metastasis in colorectal cancer.PIK3CA in Colorectal Cancer.Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer.Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing
P2860
Q26851075-C0836164-E4D1-4615-92B2-56C22FD52F50Q34008793-C70BD3E7-DED8-4718-A68C-DF60FA7D0CBAQ37151443-B5608FDC-EB6D-4154-9B95-9F29FA109864Q37612390-CD2E77B6-E5AB-425F-A463-53D449F491B2Q37678950-2058DC3A-F780-4BDD-A04E-8FF7EBE0FE54Q38238743-ED475B11-8E39-44E8-B997-268A27CB86ADQ41037621-1EE8A61D-728F-4BCD-820B-1E19AF20EEC0
P2860
Individualized therapy for metastatic colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Individualized therapy for metastatic colorectal cancer.
@en
type
label
Individualized therapy for metastatic colorectal cancer.
@en
prefLabel
Individualized therapy for metastatic colorectal cancer.
@en
P2093
P2860
P356
P1476
Individualized therapy for metastatic colorectal cancer
@en
P2093
A Huijbers
A Silvestri
E M Parasido
E Petricoin
M Pierobon
R Pellicani
P2860
P356
10.1111/JOIM.12070
P407
P577
2013-04-12T00:00:00Z